多基因评分与精神病理症状网络
该横断面研究利用ALSPAC和TEDS两个人群队列,在11岁儿童中构建包含个体症状与抑郁、焦虑、ADHD、BMI及教育程度多基因评分的心理网络。结果显示多基因评分优先与核心症状的受限子集相关,并通过特定症状间接关联其他远端症状及共病表型。
要点
- 多基因评分优先与受限的核心症状子集相关,而非所有精神科症状。
- 精神科多基因评分与特定跨诊断症状相关,非精神科评分与多种指标相关。
- 例如ADHD多基因评分与核心症状「容易分心」相关(r=0.07)。
核心结论
- 在疾病层面观察到的遗传关联可能掩盖症状层面的异质性。
- 症状层面的方法可能有助于更好理解多基因风险在塑造精神病理和共病中的作用。
研究设计与样本
- 横断面研究,使用ALSPAC和TEDS两个基于人群的队列。
- ALSPAC纳入5521名参与者(平均[SD]年龄11.8[0.14]岁;2777[50.3%]女性)。
- TEDS纳入4625名参与者(平均[SD]年龄11.27[0.69]岁;2460[53.2%]女性)。
- ALSPAC中构建包含个体症状及抑郁、焦虑、ADHD、BMI和教育程度多基因评分的心理网络,并在TEDS中按预注册验证分析进行交叉验证。
主要发现
- 多基因评分优先与受限的核心症状子集相关,并间接关联其他更远端的精神病理症状(网络边范围r=-0.074至r=0.073)。
- 精神科多基因评分与特定跨诊断症状相关,非精神科多基因评分与多种跨障碍指标相关,提示非精神科特质可能对共病有贡献。
- ADHD多基因评分与核心ADHD症状「容易分心」相关(r=0.07)。
- BMI多基因评分与跨障碍症状相关,包括「被欺负」(r=0.053)和「不把事情想透」(r=0.041)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Studies on polygenic risk for psychiatric traits commonly use a disorder-level approach to phenotyping, implicitly considering disorders as homogeneous constructs; however, symptom heterogeneity is ubiquitous, with many possible combinations of symptoms falling under the same disorder umbrella. Focusing on individual symptoms may shed light on the role of polygenic risk in psychopathology. OBJECTIVE: To determine whether polygenic scores are associated with all symptoms of psychiatric disorders or with a subset of indicators and whether polygenic scores are associated with comorbid phenotypes via specific sets of relevant symptoms. DESIGN, SETTING, AND PARTICIPANTS: Data from 2 population-based cohort studies were used in this cross-sectional study. Data from children in the Avon Longitudinal Study of Parents and Children (ALSPAC) were included in the primary analysis, and data from children in the Twins Early Development Study (TEDS) were included in confirmatory analyses. Data analysis was conducted from October 2021 to January 2024. Pregnant women based in the Southwest of England due to deliver in 1991 to 1992 were recruited in ALSPAC. Twins born in 1994 to 1996 were recruited in TEDS from population-based records. Participants with available genetic data and whose mothers completed the Short Mood and Feelings Questionnaire and the Strength and Difficulties Questionnaire when children were 11 years of age were included. MAIN OUTCOMES AND MEASURES: Psychopathology relevant symptoms, such as hyperactivity, prosociality, depression, anxiety, and peer and conduct problems at age 11 years. Psychological networks were constructed including individual symptoms and polygenic scores for depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), body mass index (BMI), and educational attainment in ALSPAC. Following a preregistered confirmatory analysis, network models were cross-validated in TEDS. RESULTS: Included were 5521 participants from ALSPAC (mean [SD] age, 11.8 [0.14] years; 2777 [50.3%] female) and 4625 participants from TEDS (mean [SD] age, 11.27 [0.69] years; 2460 [53.2%] female). Polygenic scores were preferentially associated with restricted subsets of core symptoms and indirectly associated with other, more distal symptoms of psychopathology (network edges ranged between r = -0.074 and r = 0.073). Psychiatric polygenic scores were associated with specific cross-disorder symptoms, and nonpsychiatric polygenic scores were associated with a variety of indicators across disorders, suggesting a potential contribution of nonpsychiatric traits to comorbidity. For example, the polygenic score for ADHD was associated with a core ADHD symptom, being easily distracted (r = 0.07), and the polygenic score for BMI was associated with symptoms across disorders, including being bullied (r = 0.053) and not thinking things out (r = 0.041). CONCLUSIONS AND RELEVANCE: Genetic associations observed at the disorder level may hide symptom-level heterogeneity. A symptom-level approach may enable a better understanding of the role of polygenic risk in shaping psychopathology and comorbidity.
引用
- Piazza GG, Allegrini AG, Eley TC, et al. Polygenic Scores and Networks of Psychopathology Symptoms. JAMA Psychiatry. 2024. PMID: 38865107. doi:10.1001/jamapsychiatry.2024.1403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。